|
|
0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å
Ønsker du salgsvekst?
B2B Connect er en plattform hvor bedrifter som trenger salgsmøter kan benytte seg av så mange profesjonelle møtebookere de ønsker, fra en stor pool.
Du betaler kun per booket (og gjennomført) salgsmøte, og pris per salgsmøte bestemmer du selv. Det er ingen bindinger, og ingen oppstarts- eller abonnementsavgift. Prøve oss med kun 3 møter?
| Navn | Anne Hovland |
|---|---|
| Orgnr/født år | 1978 |
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Enig AS | 102 | 100.0% | 0 | -4 | 218 | 1 |
| Knitandnote AS | 20 | 0.0% | 0 | -1 | 1 | 490 |
| Salmon Evolution ASA | 12,718 | 0.0% | 1 | -2 | 67 | 13,799 |
* Justert for eierandel
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Farvatn Medinvestering 2 AS
Via Enig AS |
33,033 | 1.7% | -0 | 1,040 | 68 | |
| Farvatn Medinvestering 2 AS
Via Enig AS |
11,033 | 0.6% | -0 | 347 | 68 | |
| Farvatn Medinvestering 2 AS
Via Enig AS |
5,687 | 0.3% | -0 | 179 | 68 | |
| Farvatn Medinvestering 1 AS
Via Enig AS |
74 | 0.2% | -0 | 328 | 10 | |
| Farvatn Medinvestering 2 AS
Via Enig AS |
4,000 | 0.2% | -0 | 126 | 68 | |
| Farvatn Medinvestering 2 AS
Via Enig AS |
3,000 | 0.2% | -0 | 94 | 68 | |
| Farvatn Medinvestering 2 AS
Via Enig AS |
1,678 | 0.1% | -0 | 53 | 68 | |
| Farvatn Medinvestering 2 AS
Via Enig AS |
1,550 | 0.1% | -0 | 49 | 68 | |
| Farvatn Medinvestering 2 AS
Via Enig AS |
1,000 | 0.1% | -0 | 31 | 68 | |
| Knitandnote AS
Via Enig AS |
60 | 0.0% | 0 | -2 | 3 | 490 |
| Bookd AS
Via Enig AS |
2,000 | 0.0% | 0 | -1 | 0 | 211 |
| Hubro Therapeutics AS
Via Enig AS |
772 | 0.0% | -6 | 7 | 43 | |
| Salmon Evolution Sales AS | 0 | 0.0% | 5 | 0 | 0 | 1 |
| Salmon Evolution International AS | 0 | 0.0% | -0 | -0 | 1 | |
| Salmon Evolution Norway AS | 3,321 | 0.0% | 5 | -2 | 3 | 1 |
| Salmon Evolution Dale AS | 0 | 0.0% | 1 | 0 | 1 | 1 |
| Farvatn Medinvestering 2 AS
Via Enig AS |
4 | 0.0% | -0 | 0 | 68 |
* Justert for eierandel
